Literature DB >> 21220771

Transmission of Cryptococcus neoformans by Organ Transplantation.

John W Baddley1, Denise C Schain, Asmita A Gupte, Sundus A Lodhi, Liise K Kayler, João P Frade, Shawn R Lockhart, Tom Chiller, J Steve Bynon, William A Bower.   

Abstract

BACKGROUND: This article describes transmission of Cryptococcus neoformans by solid organ transplantation.
METHODS: We reviewed medical records and performed molecular genotyping of isolates to determine potential for donor transmission of Cryptococcus.
RESULTS: Cryptococcosis was diagnosed in 3 recipients of organs from a common donor with an undifferentiated neurologic condition at the time of death. Cryptococcal meningoencephalitis was later diagnosed in the donor at autopsy. The liver and 1 kidney recipient developed cryptococcemia and pneumonia and the other kidney recipient developed cryptococcemia and meningitis; 2 patients recovered with prolonged antifungal therapy. We tested 4 recipient isolates with multilocus sequence typing and found they had identical alleles.
CONCLUSIONS: Our investigation documents the transmission of Cryptococcus neoformans by organ transplantation. Evaluation for cryptococcosis in donors with unexplained neurologic symptoms should be strongly considered.

Entities:  

Mesh:

Year:  2011        PMID: 21220771     DOI: 10.1093/cid/ciq216

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Guidelines for the assessment and acceptance of potential brain-dead organ donors.

Authors:  Glauco Adrieno Westphal; Valter Duro Garcia; Rafael Lisboa de Souza; Cristiano Augusto Franke; Kalinca Daberkow Vieira; Viviane Renata Zaclikevis Birckholz; Miriam Cristine Machado; Eliana Régia Barbosa de Almeida; Fernando Osni Machado; Luiz Antônio da Costa Sardinha; Raquel Wanzuita; Carlos Eduardo Soares Silvado; Gerson Costa; Vera Braatz; Milton Caldeira Filho; Rodrigo Furtado; Luana Alves Tannous; André Gustavo Neves de Albuquerque; Edson Abdala
Journal:  Rev Bras Ter Intensiva       Date:  2016-09

2.  Cryptococcosis in patients living with hepatitis C and B viruses.

Authors:  Fernanda Sá Spies; Markus Berger de Oliveira; Monique Siebra Krug; Cecilia Bittencourt Severo; Luiz Carlos Severo; Marilene Henning Vainstein
Journal:  Mycopathologia       Date:  2014-12-21       Impact factor: 2.574

Review 3.  How Environmental Fungi Cause a Range of Clinical Outcomes in Susceptible Hosts.

Authors:  Steven T Denham; Morgan A Wambaugh; Jessica C S Brown
Journal:  J Mol Biol       Date:  2019-05-09       Impact factor: 5.469

Review 4.  New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis.

Authors:  Arthur Jackson; Charles van der Horst
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

5.  Emerging invasive fungal diseases in transplantation.

Authors:  Perrine Parize; Blandine Rammaert; Olivier Lortholary
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

Review 6.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

7.  Cryptococcal infections in non-HIV-infected patients.

Authors:  Peter G Pappas
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

Review 8.  Dormancy in Cryptococcus neoformans: 60 years of accumulating evidence.

Authors:  Alexandre Alanio
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

9.  Neurological complications of solid organ transplantation.

Authors:  Amy A Pruitt; Francesc Graus; Myrna R Rosenfeld
Journal:  Neurohospitalist       Date:  2013-07

Review 10.  Invasive fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham; Kieren A Marr
Journal:  Future Microbiol       Date:  2012-05       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.